These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 21915609)

  • 1. Survival analysis of patients with dermatomyositis and polymyositis: analysis of 192 Chinese cases.
    Yu KH; Wu YJ; Kuo CF; See LC; Shen YM; Chang HC; Luo SF; Ho HH; Chen IJ
    Clin Rheumatol; 2011 Dec; 30(12):1595-601. PubMed ID: 21915609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in clinical features and prognosis of interstitial lung diseases between polymyositis and dermatomyositis.
    Fujisawa T; Suda T; Nakamura Y; Enomoto N; Ide K; Toyoshima M; Uchiyama H; Tamura R; Ida M; Yagi T; Yasuda K; Genma H; Hayakawa H; Chida K; Nakamura H
    J Rheumatol; 2005 Jan; 32(1):58-64. PubMed ID: 15630726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality of Chinese patients with polymyositis and dermatomyositis.
    Yang X; Hao Y; Zhang X; Geng Y; Ji L; Li G; Zhang Z
    Clin Rheumatol; 2020 May; 39(5):1569-1579. PubMed ID: 31902027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated therapy decreases the mortality of patients with polymyositis and dermatomyositis: A Taiwan-wide population-based retrospective study.
    Chang CM; Shih PH; Chen TJ; Ho WC; Yang CP
    J Ethnopharmacol; 2019 May; 236():70-81. PubMed ID: 30818007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of treatment on survival in polymyositis and dermatomyositis. A single-centre long-term follow-up study.
    Danieli MG; Gambini S; Pettinari L; Logullo F; Veronesi G; Gabrielli A
    Autoimmun Rev; 2014 Oct; 13(10):1048-54. PubMed ID: 25183232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interstitial lung disease in polymyositis and dermatomyositis.
    Chen IJ; Jan Wu YJ; Lin CW; Fan KW; Luo SF; Ho HH; Liou LB; Tsai WP; Chen JY; Yang CH; Kuo CF; Yu KH
    Clin Rheumatol; 2009 Jun; 28(6):639-46. PubMed ID: 19247576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients.
    Marie I; Hatron PY; Dominique S; Cherin P; Mouthon L; Menard JF
    Arthritis Rheum; 2011 Nov; 63(11):3439-47. PubMed ID: 21702020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interstitial lung disease in polymyositis and dermatomyositis.
    Marie I; Hachulla E; Chérin P; Dominique S; Hatron PY; Hellot MF; Devulder B; Herson S; Levesque H; Courtois H
    Arthritis Rheum; 2002 Dec; 47(6):614-22. PubMed ID: 12522835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis and mortality of polymyositis and dermatomyositis patients.
    Airio A; Kautiainen H; Hakala M
    Clin Rheumatol; 2006 Mar; 25(2):234-9. PubMed ID: 16477398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up of 124 patients with polymyositis and dermatomyositis: Statistical analysis of prognostic factors.
    Ishizuka M; Watanabe R; Ishii T; Machiyama T; Akita K; Fujita Y; Shirota Y; Fujii H; Harigae H
    Mod Rheumatol; 2016; 26(1):115-20. PubMed ID: 26011440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of anti-aminoacyl-tRNA synthetase antibodies in polymyositis/dermatomyositis-associated interstitial lung disease: a retrospective case control study.
    Hozumi H; Enomoto N; Kono M; Fujisawa T; Inui N; Nakamura Y; Sumikawa H; Johkoh T; Nakashima R; Imura Y; Mimori T; Suda T
    PLoS One; 2015; 10(3):e0120313. PubMed ID: 25789468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive factors and unfavourable prognostic factors of interstitial lung disease in patients with polymyositis or dermatomyositis: a retrospective study.
    Ji SY; Zeng FQ; Guo Q; Tan GZ; Tang HF; Luo YJ; Tang ZQ; Han YF
    Chin Med J (Engl); 2010 Mar; 123(5):517-22. PubMed ID: 20367973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive factors for long-term outcome in polymyositis/dermatomyositis-associated interstitial lung diseases.
    Fujisawa T; Hozumi H; Kono M; Enomoto N; Nakamura Y; Inui N; Nakashima R; Imura Y; Mimori T; Suda T
    Respir Investig; 2017 Mar; 55(2):130-137. PubMed ID: 28274528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The predictive factors and unfavourable prognostic factors of interstitial lung disease in patients with polymyositis/dermatomyositis].
    Wang PZ; Guan JL; Han XH
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Jun; 31(6):417-20. PubMed ID: 19031800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Glucocorticoids and Calcineurin Inhibitors for Anti-aminoacyl-tRNA Synthetase Antibody-positive Polymyositis/dermatomyositis-associated Interstitial Lung Disease: A Propensity Score-matched Analysis.
    Hozumi H; Fujisawa T; Nakashima R; Yasui H; Suzuki Y; Kono M; Karayama M; Furuhashi K; Enomoto N; Inui N; Nakamura Y; Mimori T; Suda T
    J Rheumatol; 2019 May; 46(5):509-517. PubMed ID: 30647164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival and outcomes after lung transplantation for connective tissue disease-associated interstitial lung diseases.
    Yang X; Wei D; Liu M; Wu B; Zhang J; Xu H; Ye S; Liu F; Hu C; Chen J
    Clin Rheumatol; 2021 Sep; 40(9):3789-3795. PubMed ID: 33755837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of Mortality in Autoimmune Myositis With and Without Associated Interstitial Lung Disease.
    Johnson C; Pinal-Fernandez I; Parikh R; Paik J; Albayda J; Mammen AL; Christopher-Stine L; Danoff S
    Lung; 2016 Oct; 194(5):733-7. PubMed ID: 27166633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease.
    Hozumi H; Fujisawa T; Nakashima R; Johkoh T; Sumikawa H; Murakami A; Enomoto N; Inui N; Nakamura Y; Hosono Y; Imura Y; Mimori T; Suda T
    Respir Med; 2016 Dec; 121():91-99. PubMed ID: 27888997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment mortality risk prediction model in patients with polymyositis/dermatomyositis-associated interstitial lung disease.
    Gui X; Li W; Jiang H; Wang R; Yu M; Zhao T; Ma M; Ding J; Jin Z; Qiu Y; Qiu X; Zhang Y; Cao M; Huang M; Cao M; Dai J; Cai H; Xin X; Xiao Y
    RMD Open; 2024 Apr; 10(2):. PubMed ID: 38663883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ventricular arrhythmia predicts poor outcome in polymyositis/dermatomyositis with myocardial involvement.
    Huang Y; Liu H; Wu C; Fang L; Fang Q; Wang Q; Fei Y; Guo X; Zhang S
    Rheumatology (Oxford); 2021 Aug; 60(8):3809-3816. PubMed ID: 33369674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.